Screening of FDA-Approved Drug Library Identifies Adefovir Dipivoxil as Highly Potent Inhibitor of T Cell Proliferation

Repositioning of approved drugs for identifying new therapeutic purposes is an alternative, time and cost saving strategy to classical drug development. Here, we screened a library of 786 FDA-approved drugs to find compounds, which can potentially be repurposed for treatment of T cell-mediated autoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Voss, Linda, Guttek, Karina, Reddig, Annika, Reinhold, Annegret, Voss, Martin, Schraven, Burkhart, Reinhold, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821167/
https://www.ncbi.nlm.nih.gov/pubmed/33488629
http://dx.doi.org/10.3389/fimmu.2020.616570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821167/
https://www.ncbi.nlm.nih.gov/pubmed/33488629
http://dx.doi.org/10.3389/fimmu.2020.616570

Ejemplares similares